26% of patients achieved more than 30% weight loss compared to 0% on lifestyle changes alone
Before starting Wegovy , inform your healthcare provider if you have: History of pancreatitis or gallbladder disease Pre-existing gastrointestinal conditions including inflammatory bowel disease or diverticular disease Severe gastrointestinal disease If you are pregnant, breastfeeding, or planning pregnancy (Wegovy must be stopped at least 2 months before planned conception) Regular follow-up with your prescribing clinician is essential to monitor treatment response, manage side effects, and ensure the medication remains appropriate for your individual circumstances
It is easy to access, and many people find it the most comfortable
Severe chronic conditions may need 12+ weeks plus ongoing maintenance
Many people on these medications report changes in their digestive system, including difficulty with bowel movements
There was a significant decrease in the death of L6 myotubes induced by PA following liraglutide treatment in a dose-dependent manner (Fig
